5-[3-fluoro-4-[5-(trifluoromethyl)thiophen-3-yl]phenyl]-1-(3H-indol-6-yl)imidazolidine-2,4-dione
C22H13F4N3O2S — CID 157385956
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[3-fluoro-4-[5-(trifluoromethyl)thiophen-3-yl]phenyl]-1-(3H-indol-6-yl)imidazolidine-2,4-dione
5-[3-fluoro-4-[5-(trifluoromethyl)thiophen-3-yl]phenyl]-1-(3H-indol-6-yl)imidazolidine-2,4-dione (PubChem CID 157385956) has the molecular formula C22H13F4N3O2S and a molecular weight of 459.42 g/mol. Its IUPAC name is 5-[3-fluoro-4-[5-(trifluoromethyl)thiophen-3-yl]phenyl]-1-(3H-indol-6-yl)imidazolidine-2,4-dione.
Molecular Properties
| Compound Name | 5-[3-fluoro-4-[5-(trifluoromethyl)thiophen-3-yl]phenyl]-1-(3H-indol-6-yl)imidazolidine-2,4-dione |
|---|---|
| PubChem CID | 157385956 |
| Molecular Formula | C22H13F4N3O2S |
| Molecular Weight | 459.42 g/mol |
| Exact Mass | 459.07 |
| IUPAC Name | 5-[3-fluoro-4-[5-(trifluoromethyl)thiophen-3-yl]phenyl]-1-(3H-indol-6-yl)imidazolidine-2,4-dione |
| SMILES | O=C1NC(=O)N(c2ccc3c(c2)N=CC3)C1c1ccc(-c2csc(C(F)(F)F)c2)c(F)c1 |
| InChI | InChI=1S/C22H13F4N3O2S/c23-16-7-12(2-4-15(16)13-8-18(32-10-13)22(24,25)26)19-20(30)28-21(31)29(19)14-3-1-11-5-6-27-17(11)9-14/h1-4,6-10,19H,5H2,(H,28,30,31) |
| InChIKey | UWODOBVDWOBBCE-UHFFFAOYSA-N |
| XLogP | 5.63 |
| TPSA | 61.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.42 |
| LogP ≤ 5 | 5.63 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydantoin', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157385956 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.